|
National Stock Number(NSN): 6505-01-316-6177 (6505013166177, 013166177)
| NIIN: |
01-316-6177 |
Item Name: |
ADENOSINE INJECTION,USP |
INC: |
77777 |
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
77777 |
| ISC: |
|
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
Feb-01-2006 |
PMIC: |
A |
FIIG: |
|
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
|
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-530-3307 |
Item Name: |
ADENOSINE INJECTION |
| FSC: |
6505 |
Replacement Date: |
Feb-01-2006 |
|
INC: |
66550 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
90-0001 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
ADENOCARD |
0K706
|
FUJISAWA PHARMACEUTICAL CO DIV OF FUJISAWA USA INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
ADENOCARD |
0M2V3
|
FUJISAWA PHARMACEUTICAL CO |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
ADENOCARD INJECTION |
0K706
|
FUJISAWA PHARMACEUTICAL CO DIV OF FUJISAWA USA INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
ADENOCARD INJECTION |
0M2V3
|
FUJISAWA PHARMACEUTICAL CO |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
ADENOCARD IV |
0K706
|
FUJISAWA PHARMACEUTICAL CO DIV OF FUJISAWA USA INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
ADENOCARD IV |
0M2V3
|
FUJISAWA PHARMACEUTICAL CO |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
ADENOCARD IV |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00469-8710-10 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC05731-7232-10 |
0K706
|
FUJISAWA PHARMACEUTICAL CO DIV OF FUJISAWA USA INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC05731-7232-10 |
0M2V3
|
FUJISAWA PHARMACEUTICAL CO |
H |
3 |
2 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
|
|
|
|
|
|
|
$0.00 |
|
|
------- |
|
H |
| DM |
S9M |
Y |
Z |
M |
|
1 |
|
$13.40 |
VI |
|
13M2--1 |
|
H |
| DN |
S9M |
V |
|
M |
|
1 |
|
$13.40 |
VI |
|
9L----A |
|
H |
| DS |
S9M |
V |
|
M |
|
1 |
|
$13.40 |
VI |
|
------- |
|
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
Z |
6505013809548 |
|
|
|
|
| DM |
K |
2 ML |
|
|
|
|
| DN |
Z |
6505013809548 |
|
|
|
|
| DS |
Z |
6505013809548 |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AJCN |
PROTECTIVE STORAGE FEATURE |
SUBJECT TO DAMAGE BY FREEZING |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
3.000 MILLIGRAMS ADENOSINE PER MILLILITER |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL,SINGLE DOSE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
2.000 MILLILITERS |
| CSGS |
ADMINISTRATION |
INTRAVENOUS |
| FEAT |
SPECIAL FEATURES |
FLIP TOP VIAL;9 MG SODIUM CHLORIDE PER ML IN WATER FOR INJECTION |
|